Chong Kun Dang loses in lawsuit

Published: 2012-05-30 06:58:00

Updated: 2012-05-30 06:58:00

Chong Kun Dang Pharmaceutical lost in a rebate lawsuit the company filed against the Ministry of Health and Welfare, claiming a 20-percent slash in drug prices is unlawful.

On Friday, the Seoul Administrative Court rejected the company’s claim, so Chong Kun Dang’s 16 drugs covered by medical i...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK